Brenda Trail
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Pharmacological Receptor Mechanisms and Effects, Mast cells and histamine, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean(2000)613 cited
- → SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist(1997)523 cited
- → GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models(2007)300 cited
- → Pharmacological Actions of a Novel, High-Affinity, and Selective Human Dopamine D3 Receptor Antagonist, SB-277011-A(2000)288 cited
- → BW 723C86, a 5-HT2B Receptor Agonist, Causes Hyperphagia and Reduced Grooming in Rats(1997)112 cited
- → Effects of the 5‐HT2B receptor agonist, BW 723C86, on three rat models of anxiety(1996)108 cited
- → SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety(2001)100 cited
- → LABORAS™: Initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour(2003)86 cited
- → Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated(1998)84 cited
- → Biarylcarbamoylindolines Are Novel and Selective 5-HT2C Receptor Inverse Agonists: Identification of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a Potential Antidepressant/Anxiolytic Agent(2000)79 cited